Search

everythinglearnresearchcommunity

for

Search:↓

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Silver nanoparticles may reduce chemotherapy side effects and improve cancer treatment.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

The committee decided not to approve the drug due to low effectiveness and high risks.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Researchers made new compounds that could potentially be developed into anticancer drugs.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.